What Researchers Did
Researchers evaluated the application of Hyperbaric Oxygen Therapy (HBO) in 14 patients with Crohn's disease (CD) refractory to standard medication and experiencing abdominal, anorectal, or skin complications.
What They Found
Of the 14 patients with refractory Crohn's disease who received Hyperbaric Oxygen Therapy, 11 (78.6%) showed a satisfactory response. This suggests that HBO may offer benefits for patients whose Crohn's disease does not respond to conventional pharmacologic treatment.
Canadian Relevance
This study was conducted in Brazil and has no direct Canadian connection.
Study Limitations
A significant limitation of this study is its small sample size of only 14 patients, which limits the generalizability of the findings.